Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (8)
Journal Articles (2)

Journal

Investigative Ophthalmology & Visual Science (10)

Article Type

ARVO Annual Meeting Abstract (8)
Cornea (1)
Immunology and Microbiology (1)

Topics

Cornea (2)
Eye Anatomy and Disorders (2)
Immunology and Microbiology (2)
Nanotechnology and Regenerative Medicine (1)
Pharmacology (1)

Tags

antimicrobials (1)
bacterial keratitis (1)
cornea (1)
disease susceptibility (1)
donors (1)
graft survival (1)
keratitis (1)
keratoplasty, penetrating (1)
organ culture techniques (1)
treatment outcome (1)

Specify Date Range

From: To: Apply

Showing 1 – 10 of 10

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Comparison of DMEK and DSAEK in high and low risk posterior lamellar keratoplasty.

Jesper Hjortdal; Uwe Pleyer; Conor C Murphy; Derek Tole; Bertrand Vabres

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1299. doi:

ARVO Annual Meeting Abstract September 2016

Ten-Year Follow-Up of Graft Survival and Visual Outcomes Following Penetrating Keratoplasty in the United Kingdom

Sing-Pey Chow; Mark N Jones; Frank Larkin; Fiona Carley; Stephen B Kaye; Francisco C Figueiredo; George Smith; Derek Tole

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):6199. doi:

ARVO Annual Meeting Abstract September 2016

Stability of visual outcome after corneal transplantation

Cathy Hopkinson; Derek Tole; Sing-Pey Chow; Mark N Jones; Stuart Cook; John Armitage

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1226. doi:

ARVO Annual Meeting Abstract September 2016

A case control study using data from the Corneal Transplant Follow-up Study II (CTFS II) to determine the influence of HLA class I matching on high-risk penetrating keratoplasty 5-year survival.

John Armitage; Mark N Jones; Helen Winton; Chris Rogers; Derek Tole; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1442. doi:

ARVO Annual Meeting Abstract June 2015

Corneal Transplant Follow-up Study II (CTFS II) - HLA class II matching does not reduce risk of allograft rejection in high-risk penetrating keratoplasty

John Armitage; Mark Jones; Helen Winton; Chris Rogers; Derek Tole; Andrew D Dick

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4358. doi:

Cornea February 2014

The Suitability of Corneas Stored by Organ Culture for Penetrating Keratoplasty and Influence of Donor and Recipient Factors on 5-Year Graft Survival

PDF

W. John Armitage; Mark N. A. Jones; Isaac Zambrano; Fiona Carley; Derek M. Tole
TAGS: cornea, donors, graft survival, keratoplasty, penetrating, organ culture techniques
Invest. Ophthalmol. Vis. Sci.. 2014; 55(2):784-791. doi: https://doi.org/10.1167/iovs.13-13386

ARVO Annual Meeting Abstract June 2013

The influence of donor factors on suitability of corneas for penetrating keratoplasty

John Armitage; Mark Jones; Isaac Zambrano; Fiona Carley; Derek Tole

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3070. doi:

ARVO Annual Meeting Abstract March 2012

Pulsed Intravenous Methylprednisolone As Adjunctive Treatment For Ocular Mucous Membrane Pemphigoid- A Pilot Randomised Clinical Trial

Valerie P. Saw; John K. Dart; Catey Bunce; Saaeha Rauz; Derek Tole; Tunde Peto; Scott Hau

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2766. doi:

ARVO Annual Meeting Abstract March 2012

Corneal Transplant Follow-up Study II (CTFS II): Patient Baseline Characteristics And Influence Of Recipient Age On Risk Of Rejection

John Armitage; Helen L. Winton; Mark N. Jones; Chris A. Rogers; Jeff L. Bidwell; Derek M. Tole; Andrew D. Dick

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2385. doi:

Immunology and Microbiology January 2010

Bacterial Susceptibility to Topical Antimicrobials and Clinical Outcome in Bacterial Keratitis

PDF

Stephen Kaye; Stephen Tuft; Timothy Neal; Derek Tole; John Leeming; Francisco Figueiredo; Malcolm Armstrong; Peter McDonnell; Andrew Tullo; Christopher Parry
TAGS: antimicrobials, bacterial keratitis, disease susceptibility, treatment outcome, keratitis, ulcer
Invest. Ophthalmol. Vis. Sci.. 2010; 51(1):362-368. doi: https://doi.org/10.1167/iovs.09-3933

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept